Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel

Fang Li, Chunlong Ma, Yanmei Hu, Yuanxiang Wang, Jun Wang

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Despite the existence of flu vaccines and small-molecule antiviral drugs, influenza virus infection remains a public health concern that warrants immediate attention. As resistance to the only orally bioavailable drug, oseltamivir, has been continuously reported, there is a clear need to develop the next-generation of anti-influenza drugs. We chose the influenza A virus M2-S31N mutant proton channel as the drug target to address this need as it is one of the most conserved viral proteins and persist in >95% of currently circulating influenza A viruses. In this study, we report the development of a late-stage diversification strategy for the expeditious synthesis of M2-S31N inhibitors. The channel blockage and antiviral activity of the synthesized compounds were tested in two-electrode voltage clamp assays and antiviral assays, respectively. Several M2-S31N inhibitors were identified to have potent M2-S31N channel blockage and micromolar antiviral efficacy against several M2-S31N-containing influenza A viruses.

Original languageEnglish (US)
Pages (from-to)726-733
Number of pages8
JournalACS Infectious Diseases
Volume2
Issue number10
DOIs
StatePublished - Oct 14 2016

Keywords

  • M2 proton channel
  • M2-S31N inhibitor
  • influenza A virus

ASJC Scopus subject areas

  • Infectious Diseases

Fingerprint Dive into the research topics of 'Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel'. Together they form a unique fingerprint.

  • Cite this